Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys
Craig Fenwick, Priscilla Turelli, Dongchun Ni, et al.
Nature Microbiology (2022) Vol. 7, Iss. 9, pp. 1376-1389
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants
Qian Wang, Sho Iketani, Zhiteng Li, et al.
Cell (2022) Vol. 186, Iss. 2, pp. 279-286.e8
Open Access | Times Cited: 743
Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses
Yanjia Chen, Xiaoyu Zhao, Hao Zhou, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 3, pp. 189-199
Open Access | Times Cited: 272
Discovery of highly neutralizing human antibodies targeting Pseudomonas aeruginosa
Alexander Simonis, Christoph Kreer, Alexandra Albus, et al.
Cell (2023) Vol. 186, Iss. 23, pp. 5098-5113.e19
Open Access | Times Cited: 25
COVID-19 therapeutics
Daniele Focosi, Massimo Franchini, Fabrizio Maggi, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 10
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants
Qian Wang, Sho Iketani, Zhiteng Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 29
Cryo-EM structures and binding of mouse and human ACE2 to SARS-CoV-2 variants of concern indicate that mutations enabling immune escape could expand host range
Dongchun Ni, Priscilla Turelli, Bertrand Beckert, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 4, pp. e1011206-e1011206
Open Access | Times Cited: 20
Genomic screening of 16 UK native bat species through conservationist networks uncovers coronaviruses with zoonotic potential
Cedric C.S. Tan, Jahcub Trew, Thomas P. Peacock, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2
Qian Wang, Zhiteng Li, Yicheng Guo, et al.
iScience (2023) Vol. 26, Iss. 11, pp. 108254-108254
Open Access | Times Cited: 18
A vaccine targeting antigen-presenting cells through CD40 induces protective immunity against Nipah disease
Yadira Pastor, Olivier Reynard, Mathieu Iampietro, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 3, pp. 101467-101467
Open Access | Times Cited: 5
Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort
Dominik Menges, Kyra D. Zens, Tala Ballouz, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 25
A First-in-Human Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Investigational Long-Acting Anti-SARS-CoV-2 Monoclonal Antibodies
Norman Moullan, Josephat Asiago, Kathryn Stecco, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 1, pp. 173-187
Open Access | Times Cited: 4
Sotrovimab retains activity against SARS-CoV-2 omicron variant BQ.1.1 in a non-human primate model
Cécile Herate, Romain Marlin, Franck Touret, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e16664-e16664
Open Access | Times Cited: 10
New nickel(ii) Schiff base complexes as potential tools against SARS-CoV-2 Omicron target proteins: an in silico approach
Sunil Kumar, Mukesh Choudhary
New Journal of Chemistry (2023) Vol. 47, Iss. 5, pp. 2350-2371
Closed Access | Times Cited: 9
Distinct Conformations of SARS-CoV-2 Omicron Spike Protein and Its Interaction with ACE2 and Antibody
Myeongsang Lee, Marian Major, Huixiao Hong
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3774-3774
Open Access | Times Cited: 9
Concerns on Bebtelovimab (LY‐CoV1404) used to neutralize Omicron subvariants
Xuejun Wang, Yang Yang, Zhifei Song, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 8
Predicting changes in neutralizing antibody activity for SARS-CoV-2 XBB.1.5 using in silico protein modeling
Colby T. Ford, Shirish Yasa, Denis Jacob Machado, et al.
Frontiers in Virology (2023) Vol. 3
Open Access | Times Cited: 8
Licorice-saponin A3 is a broad-spectrum inhibitor for COVID-19 by targeting viral spike and anti-inflammation
Yi Yang, Wenzhe Li, Kefang Liu, et al.
Journal of Pharmaceutical Analysis (2023) Vol. 14, Iss. 1, pp. 115-127
Open Access | Times Cited: 8
Genetic barrier to resistance: a critical parameter for efficacy of neutralizing monoclonal antibodies against SARS-CoV-2 in a nonhuman primate model
Christiane Stahl‐Hennig, Antonia Sophia Peter, Arne Cordsmeier, et al.
Journal of Virology (2024) Vol. 98, Iss. 7
Open Access | Times Cited: 2
Sotrovimab retains activity against SARS-CoV-2 Omicron variant BQ.1.1 in a non-human primate model
Cécile Herate, Romain Marlin, Franck Touret, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2
Qian Wang, Zhiteng Li, Yicheng Guo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Cryo-EM structures and binding of mouse and human ACE2 to SARS-CoV-2 variants of concern indicate that mutations enabling immune escape could expand host range
Dongchun Ni, Priscilla Turelli, Bertrand Beckert, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 17
P2G3 human monoclonal antibody neutralizes SARS-CoV-2 Omicron subvariants including BA.4 and BA.5 and Bebtelovimab escape mutants
Priscilla Turelli, Craig Fenwick, Charlène Raclot, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 11
Potent antibodies against immune invasive SARS-CoV-2 Omicron subvariants
Lidong Wang, Yang Wang, Hao Zhou
International Journal of Biological Macromolecules (2023) Vol. 249, pp. 125997-125997
Closed Access | Times Cited: 6
Genomic architecture and evolutionary relationship of BA.2.75: A Centaurus subvariant of Omicron SARS-CoV-2
Atia Basheer, Imran Zahoor, Tahir Yaqub
PLoS ONE (2023) Vol. 18, Iss. 5, pp. e0281159-e0281159
Open Access | Times Cited: 5
Broadly potent anti-SARS-CoV-2 antibody shares 93% of epitope with ACE2 and provides full protection in monkeys
Craig Fenwick, Priscilla Turelli, Yoan Duhoo, et al.
Journal of Infection (2023) Vol. 87, Iss. 6, pp. 524-537
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top